Literature DB >> 33246040

Hysteroscopy for Assessing Fallopian Tubal Obstruction: A Systematic Review and Diagnostic Test Accuracy Meta-analysis.

Salvatore Giovanni Vitale1, Jose Carugno2, Gaetano Riemma3, Péter Török4, Stefano Cianci3, Pasquale De Franciscis3, John Preston Parry5.   

Abstract

OBJECTIVE: To assess the diagnostic accuracy of hysteroscopy compared with that of laparoscopic chromopertubation for the detection of fallopian tubal obstruction. DATA SOURCES: An electronic search from inception to March 31, 2020, was performed in Medline, Scopus, EMBASE, and the Cochrane Central Register of Controlled Trials. METHODS OF STUDY SELECTION: This diagnostic accuracy meta-analysis was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Synthesizing Evidence from Diagnostic Accuracy Tests recommendations. A combination of the following Medical Subject Headings terms and keywords was included in the search strategy: "hysteroscopy[MeSH]," "tubal obstruction," "tubal patency," "tubal dysfunction," and "tubal blockage." Quality assessment of the included studies was conducted using the Quality Assessment Tool for Diagnostic Accuracy Studies-2 (University of Bristol, Bristol, United Kingdom). Publication bias was evaluated by means of the Deek funnel plot asymmetry test. The following outcomes were analyzed: diagnostic odds ratio, area under hierarchical summary receiver operating characteristic and area under receiver operating characteristic curve, sensitivity, specificity, and positive and negative likelihood ratios. TABULATION, INTEGRATION, AND
RESULTS: Six studies comparing hysteroscopy with laparoscopic chromopertubation were included in the meta-analysis. After pooling all the studies, the diagnostic odds ratio was 43. The evaluated area under receiver operating characteristic curve was 0.93, correlating with high diagnostic accuracy for the index test. Sensitivity and specificity were 88% and 85%, respectively. In addition, the positive and negative likelihood ratios were 5.88 and 0.16, respectively.
CONCLUSION: Hysteroscopic techniques are highly accurate and sensitive for detecting fallopian tubal obstruction. Interventional assessment enhances diagnostic accuracy compared with observational assessment, as does the office setting compared with the operating room. Additional studies, along with a refinement of the techniques, could facilitate the widespread use of hysteroscopic techniques for the detection of fallopian tube occlusion.
Copyright © 2020 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chromopertubation; Infertility; Tubal patency

Year:  2020        PMID: 33246040     DOI: 10.1016/j.jmig.2020.11.013

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  4 in total

Review 1.  Surgical management of endocervical and decidual polyps during pregnancy: systematic review and meta-analysis.

Authors:  Gaetano Riemma; Luigi Della Corte; Salvatore Giovanni Vitale; Stefano Cianci; Marco La Verde; Pierluigi Giampaolino; Luigi Cobellis; Pasquale De Franciscis
Journal:  Arch Gynecol Obstet       Date:  2022-04-09       Impact factor: 2.344

Review 2.  Ultra-minimally invasive surgery in gynecological patients: a review of the literature.

Authors:  Marco La Verde; Gaetano Riemma; Alessandro Tropea; Antonio Biondi; Stefano Cianci
Journal:  Updates Surg       Date:  2022-04-02

3.  Preliminary hysteroscopic tubal hydrotubation improves fertility outcomes after laparoscopic salpingotomy for tubal ampullary pregnancy.

Authors:  Qing Wu; Yanling Lin; Jing Zhang; Yun Zhou; Lifeng Chen; Tan Lin
Journal:  BMC Surg       Date:  2022-02-12       Impact factor: 2.102

4.  Technical Tips and Tricks after 10 Years of HyFoSy for Tubal Patency Testing.

Authors:  Roxana-Elena Bohîlțea; Bianca-Margareta Mihai; Cătălina-Diana Stănică; Consuela-Mădălina Gheorghe; Costin Berceanu; Vlad Dima; Alexia-Teodora Bohîlțea; Smaranda Neagu; Radu Vlădăreanu
Journal:  J Clin Med       Date:  2022-10-08       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.